Abstract
The asymptomatic and clinical stages of Parkinson’s disease (PD) are associated with comorbid non-motor symptoms including gastrointestinal (GI) dysfunction. Although the neuroprotective and gastroprotective roles of kolaviron (KV) have been reported independently, whether KV-mediated GI-protective capacity could be beneficial in PD is unknown. We therefore investigated the modulatory effects of KV on the loss of dopaminergic neurons, locomotor abnormalities, and ileal oxidative damage when rats are lesioned in the nigrostriatal pathway. KV treatment markedly suppressed the behavioral deficit and apomorphine-induced rotations associated with rotenone lesioning. KV attenuated the loss of nigrostriatal dopaminergic neurons and perturbations in the striatal glucose-regulated protein (GRP78) and X-box binding protein 1 (XBP1) levels. Ileal epithelial injury following stereotaxic rotenone infusion was associated with oxidative stress and marked inhibition of acetylcholine esterase activity and reduced expression of occludin in the crypt and villi. While KV treatment attenuated the redox imbalance in the gut and enhanced occludin immunoreactivity, acetylcholinesterase activity was not affected. Our data demonstrate ileal oxidative damage as a characteristic non-motor gut dysfunction in PD while showing the potential dual efficacy of KV in the attenuation of both neural defects and gut abnormalities associated with PD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abarikwu SO, Farombi EO, Pant AB (2011) Biflavanone-kolaviron protects human dopaminergic SH-SY5Y cells against atrazine induced toxic insult. Toxicol Vitr 25:848–858. https://doi.org/10.1016/j.tiv.2011.02.005
Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson’s disease: mechanisms of action. Drug Discov Today 21:802–818
Ayepola OR, Chegou NN, Brooks NL, Oguntibeju OO (2013) Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses. BMC Complement Altern Med 13:363. https://doi.org/10.1186/1472-6882-13-363
Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211. https://doi.org/10.1016/S0197-4580(02)00065-9
Bradford M (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–252
Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J (2004) Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death. FASEB J 18:1162–1164. https://doi.org/10.1096/fj.04-1551fje
Cherubini M, Wade-Martins R (2018) Convergent pathways in Parkinson’s disease. Cell Tissue Res 373:79–90
Clairborne A (1995) Catalase activity. In handbook of methods for oxygen radical research. CRC Press, Florida
Coelho DS, Domingos PM (2014) Physiological roles of regulated Ire1 dependent decay. Front Genet 5. https://doi.org/10.3389/fgene.2014.00076
Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701–712
Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, Pahan K, Shannon KM, Keshavarzian A (2020) Chronic stress-induced gut dysfunction exacerbates Parkinson’s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson’s disease. Neurobiol Dis 135:104352. https://doi.org/10.1016/j.nbd.2018.12.012
Ellman GL, Courtney KD, Andres VJ, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Enogieru AB, Omoruyi SI, Hiss DC, Ekpo OE (2019) GRP78/BIP/HSPA5 as a therapeutic target in models of Parkinson’s disease: a mini review. Adv Pharmacol Sci 2019:1–11
Farombi EO, Owoeye O (2011) Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid. Int J Environ Res Public Health 8:2533–2555. https://doi.org/10.3390/ijerph8062533
Farombi EO, Møller P, Dragsted LO (2004) Ex-vivo and in vitro protective effects of kolaviron against oxygen-derived radical-induced DNA damage and oxidative stress in human lymphocytes and rat liver cells. Cell Biol Toxicol 20:71–82
Farombi EO, Adedara IA, Ajayi BO, Ayepola OR, Egbeme EE (2013) Kolaviron, a natural antioxidant and anti-inflammatory phytochemical prevents dextran sulphate sodium-induced colitis in rats. Basic Clin Pharmacol Toxicol 113:49–55. https://doi.org/10.1111/bcpt.12050
Farombi EO, Awogbindin IO, Farombi TH, Oladele JO, Izomoh ER, Aladelokun OB, Ezekiel IO, Adebambo OI, Abah VO (2019) Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson’s disease. Neurotoxicology 73:132–141. https://doi.org/10.1016/j.neuro.2019.03.005
Forsythe P, Bienenstock J, Kunze WA (2014) Vagal pathways for microbiome-brain-gut axis communication. Adv Exp Med Biol 817:115–133. https://doi.org/10.1007/978-1-4939-0897-4_5
Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS (2011) Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson’s disease. Environ Health Perspect 119:807–814
Ghribi O, Herman MM, Pramoonjago P, Savory J (2003) MPP + induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-κB signaling pathways. J Neuropathol Exp Neurol 62:1144–1153. https://doi.org/10.1093/jnen/62.11.1144
Gjerløff T, Fedorova T, Knudsen K, Munk OL, Nahimi A, Jacobsen S, Danielsen EH, Terkelsen AJ, Hansen J, Pavese N, Brooks DJ, Borghammer P (2015) Imaging acetylcholinesterase density in peripheral organs in Parkinson’s disease with 11 C-donepezil PET. Brain 138:653–663. https://doi.org/10.1093/brain/awu369
Gorbatyuk MS, Shabashvili A, Chen W, Meyers C, Sullivan LF, Salganik M, Lin JH, Lewin AS, Muzyczka N, Gorbatyuk OS (2012) Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of parkinson disease. Mol Ther 20:1327–1337. https://doi.org/10.1038/mt.2012.28
Goswami P, Gupta S, Biswas J, Sharma S, Singh S (2016) Endoplasmic reticulum stress instigates the rotenone induced oxidative apoptotic neuronal death: a study in rat brain. Mol Neurobiol 53:5384–5400. https://doi.org/10.1007/s12035-015-9463-0
Greene JG, Noorian AR, Srinivasan S (2009) Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson’s disease. Exp Neurol 218:154–161. https://doi.org/10.1016/j.expneurol.2009.04.023
Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139
Haikal C, Chen Q-Q, Li J-Y (2019) Microbiome changes: an indicator of Parkinson’s disease? Transl Neurodegener 8:38. https://doi.org/10.1186/s40035-019-0175-7
Hancock DB, Martin ER, Mayhew GM, Stajich JM, Jewett R, Stacy MA, Scott BL, Vance JM, Scott WK (2008) Pesticide exposure and risk of Parkinson’s disease: a family-based case-control study. BMC Neurol 8:6. https://doi.org/10.1186/1471-2377-8-6
Homayoun H (2018) Parkinson disease. Ann Intern Med 169:ITC33–ITC47. https://doi.org/10.7326/AITC201809040
Igado OO, Olopade JO, Adesida AA, Aina OO, Farombi EO (2012) Morphological and biochemical investigation into the possible neuroprotective effects of kolaviron (Garcinia kola bioflavonoid) on the brains of rats exposed to vanadium. Drug Chem Toxicol 35:371–380
Iwu MM (1986) Biflavanones of Garcinia: pharmacological and biological activities. Prog Clin Biol Res 213:485–488
Iwu MM, Igboko OA, Onwuchekwa U, Okunji CO (1987) Evaluation of the antihepatotoxicity of the biflavanoids of Garcinia kola seeds. J Ethnopharmacol 21:127–142
Jiang P, Dickson DW (2018) Parkinson’s disease: experimental models and reality. Acta Neuropathol 135:13–32
Jiang M, Yun Q, Shi F, Niu G, Gao Y, Xie S, Yu S (2016) Downregulation of miR-384-5p attenuates rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through inhibiting endoplasmic reticulum stress. Am J Physiol Physiol 310:C755–C763. https://doi.org/10.1152/ajpcell.00226.2015
Jollow D, Mitchell J, Zampaglione N, Gillette J (1974) Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4 bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151–169
Khadrawy YA, Salem AM, El-Shamy KA et al (2017) Neuroprotective and therapeutic effect of caffeine on the rat model of Parkinson’s disease induced by rotenone. J Diet Suppl 14:553–572. https://doi.org/10.1080/19390211.2016.1275916
Klingelhoefer L, Reichmann H (2017) The gut and nonmotor symptoms in Parkinson’s disease. In: International Review of Neurobiology. Academic Press Inc., pp 787–809
Law NM, Bharucha AE, Undale AS, Zinsmeister AR (2001) Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans. Am J Physiol - Gastrointest Liver Physiol 281:G1228–G1237. https://doi.org/10.1152/ajpgi.2001.281.5.g1228
Li HF, Zhao SX, Xing BP, Sun ML (2015) Ulinastatin suppresses endoplasmic reticulum stress and apoptosis in the hippocampus of rats with acute paraquat poisoning. Neural Regen Res 10:467–472. https://doi.org/10.4103/1673-5374.153698
Mezias C, Rey N, Brundin P, Raj A (2020) Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation. Neurobiol Dis:134. https://doi.org/10.1016/j.nbd.2019.104623
Murakami S, Miyazaki I, Sogawa N, Miyoshi K, Asanuma M (2014) Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in parkinsonian mice. Neurotox Res 26:285–298. https://doi.org/10.1007/s12640-014-9480-1
Olaleye SB, Farombi EO (2006) Attenuation of indomethacin- and HCl/ethanol-induced oxidative gastric mucosa damage in rats by kolaviron, a natural biflavonoid of Garcinia kola seed. Phyther Res 20:14–20. https://doi.org/10.1002/ptr.1793
Olaleye SB, Farombi EO, Adewoye EA et al (2000) Analgesic and anti-inflammatory effects of Kolaviron (a Garcinia Kola seed extract). Afr J Biomed Res 3:171–174
Oluwole OG, Kuivaniemi H, Carr JA, Ross OA, Olaogun MOB, Bardien S, Komolafe MA (2019) Parkinson’s disease in Nigeria: a review of published studies and recommendations for future research. Parkinsonism Relat Disord 62:36–43. https://doi.org/10.1016/j.parkreldis.2018.12.004
Omotoso GO, Ukwubile II, Arietarhire L, Sulaimon F, Gbadamosi IT (2018) Kolaviron protects the brain in cuprizone-induced model of experimental multiple sclerosis via enhancement of intrinsic antioxidant mechanisms: possible therapeutic applications? Pathophysiology 25:299–306. https://doi.org/10.1016/j.pathophys.2018.04.004
Onasanwo SA, Ilenre KO, Faborode SO (2015) The impact of Kolaviron (a bioflavonoid of Garcinia Kola seed) on depression status in laboratory rodents: roles of Monoaminergic systems. Ann Depress Anxiety 2:1042
Onasanwo SA, Velagapudi R, El-Bakoush A, Olajide OA (2016) Inhibition of neuroinflammation in BV2 microglia by the biflavonoid kolaviron is dependent on the Nrf2/ARE antioxidant protective mechanism. Mol Cell Biochem 414:23–36. https://doi.org/10.1007/s11010-016-2655-8
Owoeye O, Adedara IA, Farombi EO (2018) Pretreatment with taurine prevented brain injury and exploratory behaviour associated with administration of anticancer drug cisplatin in rats. Biomed Pharmacother 102:375–384. https://doi.org/10.1016/j.biopha.2018.03.051
Perez-Pardo P, Broersen LM, Kliest T, van Wijk N, Attali A, Garssen J, Kraneveld AD (2018a) Additive effects of levodopa and a neurorestorative diet in a mouse model of Parkinson’s disease. Front Aging Neurosci 10:237. https://doi.org/10.3389/fnagi.2018.00237
Perez-Pardo P, Dodiya HB, Broersen LM, Douna H, van Wijk N, Lopes da Silva S, Garssen J, Keshavarzian A, Kraneveld AD (2018b) Gut–brain and brain–gut axis in Parkinson’s disease models: effects of a uridine and fish oil diet. Nutr Neurosci 21:391–402. https://doi.org/10.1080/1028415X.2017.1294555
Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, Voigt RM, Naqib A, Green SJ, Kordower JH, Shannon KM, Garssen J, Kraneveld AD, Keshavarzian A (2019) Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice. Gut 68:829–843. https://doi.org/10.1136/gutjnl-2018-316844
Rea K, Dinan TG, Cryan JF (2016) The microbiome: a key regulator of stress and neuroinflammation. Neurobiol Stress 4:23–33
Salcedo I, Tweedie D, Li Y, Greig NH (2012) Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Br J Pharmacol 166:1586–1599
Salganik M, Sergeyev VG, Shinde V, Meyers CA, Gorbatyuk MS, Lin JH, Zolotukhin S, Gorbatyuk OS (2015) The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (α-syn) toxicity to rat nigral neurons. Neurobiol Aging 36:2213–2223. https://doi.org/10.1016/j.neurobiolaging.2015.02.018
Singh SP, Chand HS, Banerjee S, Agarwal H, Raizada V, Roy S, Sopori M (2020) Acetylcholinesterase inhibitor pyridostigmine bromide attenuates gut pathology and bacterial Dysbiosis in a murine model of ulcerative colitis. Dig Dis Sci 65:141–149. https://doi.org/10.1007/s10620-019-05838-6
Tysnes OB, Storstein A (2017) Epidemiology of Parkinson’s disease. J Neural Transm 124:901–905
Ulusoy A, Rusconi R, Pérez-Revuelta BI, Musgrove RE, Helwig M, Winzen-Reichert B, Monte DAD (2013) Caudo-rostral brain spreading of α-synuclein through vagal connections. EMBO Mol Med 5:1051–1059. https://doi.org/10.1002/emmm.201302475
Varshney R, Kale R (1990) Effect of calmodulin antagonists on radiation induced lipid peroxidation in microsomes. Int J Radiat Biol 58:733–743
Xiong N, Huang J, Zhang Z, Zhang Z, Xiong J, Liu X, Jia M, Wang F, Chen C, Cao X, Liang Z, Sun S, Lin Z, Wang T (2009) Stereotaxical infusion of rotenone : a reliable rodent model for Parkinson’s disease. PLoS One 4:e7878. https://doi.org/10.1371/journal.pone.0007878
Yajima T, Inoue R, Matsumoto M, Yajima M (2011) Non-neuronal release of ACh plays a key role in secretory response to luminal propionate in rat colon. J Physiol 589:953–962. https://doi.org/10.1113/jphysiol.2010.199976
Yang X, Qian Y, Xu S, Song Y, Xiao Q (2018) Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson’s disease. Front Aging Neurosci 9:441. https://doi.org/10.3389/fnagi.2017.00441
Yen J, Donerly S, Levin ED, Linney EA (2011) Differential acetylcholinesterase inhibition of chlorpyrifos, diazinon and parathion in larval zebrafish. Neurotoxicol Teratol 33:735–741. https://doi.org/10.1016/j.ntt.2011.10.004
Funding
This work was supported by the TETFUND National Research Fund (NRF) 2015; the grant is awarded to Professor E.O. Farombi.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Farombi, E.O., Awogbindin, I.O., Olorunkalu, P.D. et al. Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson’s disease. Psychopharmacology 237, 3225–3236 (2020). https://doi.org/10.1007/s00213-020-05605-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-020-05605-w